agilon health, inc. (NYSE:AGL – Get Rating) has earned a consensus recommendation of “Moderate Buy” from the ten research firms that are presently covering the company, Marketbeat.com reports. One analyst has rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 1-year target price among brokerages that have issued ratings on the stock in the last year is $28.63.
Several research analysts recently issued reports on AGL shares. Guggenheim lifted their target price on agilon health from $21.00 to $30.00 and gave the company a “buy” rating in a research report on Monday, March 6th. Stifel Nicolaus assumed coverage on agilon health in a research report on Thursday, December 8th. They issued a “buy” rating and a $23.00 price objective on the stock. Finally, Deutsche Bank Aktiengesellschaft boosted their price objective on agilon health from $26.00 to $28.00 in a research report on Friday, March 3rd.
Insider Buying and Selling at agilon health
In other agilon health news, insider Benjamin Kornitzer sold 5,398 shares of the business’s stock in a transaction on Friday, December 16th. The stock was sold at an average price of $16.82, for a total value of $90,794.36. Following the sale, the insider now directly owns 10,426 shares in the company, valued at $175,365.32. The sale was disclosed in a filing with the SEC, which is accessible through this link. In related news, insider Benjamin Shaker sold 28,555 shares of the business’s stock in a transaction on Wednesday, February 15th. The stock was sold at an average price of $23.37, for a total transaction of $667,330.35. Following the sale, the insider now directly owns 25,625 shares in the company, valued at approximately $598,856.25. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Benjamin Kornitzer sold 5,398 shares of the business’s stock in a transaction on Friday, December 16th. The shares were sold at an average price of $16.82, for a total value of $90,794.36. Following the sale, the insider now owns 10,426 shares in the company, valued at $175,365.32. The disclosure for this sale can be found here. Insiders have sold a total of 70,864 shares of company stock worth $1,515,177 over the last ninety days. 3.30% of the stock is currently owned by company insiders.
Institutional Trading of agilon health
agilon health Stock Up 1.0 %
Shares of NYSE:AGL opened at $23.91 on Thursday. The stock has a market cap of $9.88 billion, a price-to-earnings ratio of -91.96 and a beta of 1.09. The company has a quick ratio of 2.71, a current ratio of 2.71 and a debt-to-equity ratio of 0.04. agilon health has a 12-month low of $14.82 and a 12-month high of $28.36. The business’s 50 day moving average is $21.55 and its 200 day moving average is $20.34.
agilon health Company Profile
agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2021, it served approximately 238,000 senior members, which included 186,300 medicare advantage members and 51,700 medicare fee-for-service beneficiaries.
- Get a free copy of the StockNews.com research report on agilon health (AGL)
- Meta Platforms: Efficiency Gains Momentum, Stock Accelerates
- Pfizer’s Latest Acquisition Strengthens the Case for PFE Stock
- SentinelOne: Reversal In-Play For Cybersecurity Stocks
- Is Sportradar Group A Growth Stock To Bet On In 2023?
- Strong Guidance says Boeing is Ready for Takeoff
Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.